{"id":3292,"date":"2025-11-14T11:27:07","date_gmt":"2025-11-14T10:27:07","guid":{"rendered":"https:\/\/biotechaustria.org\/mitarbeiter\/thomas-moser\/"},"modified":"2026-03-16T08:43:05","modified_gmt":"2026-03-16T07:43:05","slug":"thomas-moser","status":"publish","type":"mitarbeiter","link":"https:\/\/biotechaustria.org\/en\/mitarbeiter\/thomas-moser\/","title":{"rendered":"THOMAS MOSER"},"content":{"rendered":"<p>Dr. Thomas Moser brings over 25 years of experience in venture financing, IP commercialization, venture capital, and innovative start-ups. He is the founder and CEO of Myllia Biotechnology and serves as CFO\/COO of bit.bio discovery in Vienna. The company leverages an advanced CRISPR screening platform to identify novel therapeutic targets in partnership with leading pharmaceutical and biotech companies.<\/p>\n","protected":false},"featured_media":2914,"parent":0,"template":"","kategorie_mitarbeiter":[43],"class_list":["post-3292","mitarbeiter","type-mitarbeiter","status-publish","has-post-thumbnail","hentry","kategorie_mitarbeiter-vorstand"],"acf":[],"_links":{"self":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/mitarbeiter\/3292","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/mitarbeiter"}],"about":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/types\/mitarbeiter"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/media\/2914"}],"wp:attachment":[{"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/media?parent=3292"}],"wp:term":[{"taxonomy":"kategorie_mitarbeiter","embeddable":true,"href":"https:\/\/biotechaustria.org\/en\/wp-json\/wp\/v2\/kategorie_mitarbeiter?post=3292"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}